- Home
- BIRK vs RVMD Comparison
BIRK vs RVMD Comparison
Compare BIRK & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIRK
- RVMD
- Stock Information
- Founded
- BIRK 1774
- RVMD 2014
- Country
- BIRK United Kingdom
- RVMD United States
- Employees
- BIRK N/A
- RVMD N/A
- Industry
- BIRK
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BIRK
- RVMD Health Care
- Exchange
- BIRK Nasdaq
- RVMD Nasdaq
- Market Cap
- BIRK 8.8B
- RVMD 7.5B
- IPO Year
- BIRK 2023
- RVMD 2020
- Fundamental
- Price
- BIRK $50.13
- RVMD $40.50
- Analyst Decision
- BIRK Strong Buy
- RVMD Strong Buy
- Analyst Count
- BIRK 11
- RVMD 14
- Target Price
- BIRK $68.27
- RVMD $71.93
- AVG Volume (30 Days)
- BIRK 1.9M
- RVMD 2.0M
- Earning Date
- BIRK 08-14-2025
- RVMD 11-05-2025
- Dividend Yield
- BIRK N/A
- RVMD N/A
- EPS Growth
- BIRK 178.47
- RVMD N/A
- EPS
- BIRK 1.92
- RVMD N/A
- Revenue
- BIRK $2,380,334,704.00
- RVMD N/A
- Revenue This Year
- BIRK $17.97
- RVMD N/A
- Revenue Next Year
- BIRK $14.51
- RVMD $387.56
- P/E Ratio
- BIRK $26.11
- RVMD N/A
- Revenue Growth
- BIRK 17.60
- RVMD N/A
- 52 Week Low
- BIRK $40.56
- RVMD $29.17
- 52 Week High
- BIRK $62.66
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- BIRK 47.69
- RVMD 65.02
- Support Level
- BIRK $49.21
- RVMD $38.49
- Resistance Level
- BIRK $52.89
- RVMD $40.98
- Average True Range (ATR)
- BIRK 1.34
- RVMD 1.53
- MACD
- BIRK -0.13
- RVMD 0.45
- Stochastic Oscillator
- BIRK 21.30
- RVMD 89.28
About BIRK Birkenstock Holding plc
Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.